Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Telo Genomics Corp V.TELO

Alternate Symbol(s):  TDSGF

Telo Genomics Corp is a personalized medicine company. The company through its wholly-owned subsidiary is engaged in the development and commercialization of diagnostic and prognostic products. The company is developing diagnostic and prognostic products for cancer and neurological disorders.

The Market Herald Price Sensitive
{{currentVideo.title}} {{currentVideo.relativeTime}}
{{currentVideo.storiesTitle}}:
{{story.companySymbol}}
{{story.companySymbol}} {{story.headline}}
< Previous bulletin
Next bulletin >
View modes: 

Telo Announces Validation of Its Proprietary Tools for SMM

Telo Genomics Announces Successful Validation of Its Proprietary Automation Tools for Smoldering Multiple Myeloma Toronto, Ontario--(Newsfile Corp. - May 31, 2022) - Telo Genomics Corp. (TSXV...read more

huge volume

Something good must be up for this volume of today.  rate and reply

Telo Clinical Validation of its Smoldering Myeloma Test

Telo Genomics Launches Clinical Validation of its Smoldering Multiple Myeloma Diagnostic Test Toronto, Ontario--(Newsfile Corp. - March 7, 2022) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF...read more

RE:news

Dr. McGlennen is a strong addition to the Telo team that should prove beneficial in taking Telo to commercialization. https://www.telodx.com  rate and reply

news

Telo Genomics Appoints Dr. McGlennen as Board Director, a Leader in Commercializing Novel Diagnostic Technologies Toronto, Ontario--(Newsfile Corp. - February 3, 2022) - Telo Genomics Corp...read more

Telo Genomics Advances Its Lead Product

Telo Genomics Advances Its Lead Product and Implements Automation to Its Workflow Toronto, Ontario--(Newsfile Corp. - January 19, 2022) - Telo Genomics Corp. (TSXV: TELO) (the "...read more

news

Telo Genomics Announces the Outcome of its Participation in the International Myeloma Workshop and Clinical Studies Progress Toronto, Ontario--(Newsfile Corp. - October 13, 2021) - Telo...read more

Telo Genomics w CEO Sherif Louis - Pitch, Interview + Q&A

Telo Genomics (TELO) w CEO Sherif Louis - Pitch, Interview, Discussion, Deep Dive & Q&A - The World’s Leading Telomere-Based Diagnostic/Prognostic Platform - https://www.youtube.com/watch...read more

Webinar - TELO w/ CEO Sherif Louis Thu Sep 23 @ 2PM ET

Webinar - Telo Genomics Corp. (TELO) w/ CEO Sherif Louis Thur September 23 at 2pm ET / 11am PT Q&A with Radius Research  Register Here - https://us02web.zoom.us/webinar/register...read more

news

Telo Genomics Participates in the 18th International Myeloma Society Workshop 2021 Toronto, Ontario--(Newsfile Corp. - September 9, 2021) - Telo Genomics Corp. (TSXV: TELO) (the "...read more

Telo Engages Clinical and Regulatory Affairs Veteran

Telo Genomics Engages Clinical and Regulatory Affairs Veteran to Lead the Company's ISO 15189 Certification & CLIA Laboratory Accreditation Undertaking Toronto, Ontario--(Newsfile Corp...read more

insider activity

Date Name Shares Traded Value Shares Held   2021-07-02 Meekison, William John 10,000 $5,000...read more

RE:Completes Final Tranche of Oversubscribed Private Placement

Completed quickly also  rate and reply

news

Telo Genomics Completes First Tranche of Oversubscribed Private Placement Toronto, Ontario--(Newsfile Corp. - July 2, 2021) - Telo Genomics Corp. (TSXV: TELO) (the "Company" or...read more

news

Telo Genomics Announces Private Placement of Units Toronto, Ontario--(Newsfile Corp. - June 18, 2021) - Telo Genomics Corp. (TSXV: TELO) (the "Company" or "TELO") is...read more